Abde Abukhdeir to Receptor, ErbB-2
This is a "connection" page, showing publications Abde Abukhdeir has written about Receptor, ErbB-2.
Connection Strength
0.219
-
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells. PLoS One. 2020; 15(6):e0234146.
Score: 0.174
-
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer. Clin Cancer Res. 2021 04 15; 27(8):2126-2129.
Score: 0.045